BRAF and MEK inhibitors differentially affect nivolumab-induced T cell activation by modulating the TCR and AKT signaling pathways.
ONCOIMMUNOLOGY（2019）
关键词
Melanoma,Nivolumab,BRAF inhibitor,MEK inhibitor,T cell activation
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要